• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    BetterInvesting™ Magazine Update on Lowe's Cos. (NYSE: LOW) and ICON PLC (NASDAQ: ICLR)

    3/24/25 5:09:00 PM ET
    $ICLR
    $LOW
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    RETAIL: Building Materials
    Consumer Discretionary
    Get the next $ICLR alert in real time by email

    TROY, Mich., March 24, 2025 /PRNewswire/ -- Lowe's recent report has investors wondering if the company's stock is overvalued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine considers Lowe's Cos. (NYSE:LOW) as worthy of further study and has named the company its "Stock to Study" for the June/July 2025 double issue for investors' informational and educational use.

    The fundamental data is eye-opening; investors can view Lowe's sales, earnings, pre-tax profit, return on equity, and more all on one page, courtesy of the National Association of Investors, at: https://ssg.betterinvesting.org/trial/ssgplus/?ticker=LOW.

    A full report on Lowe's Cos. will appear in the June/July 2025 issue of BetterInvesting Magazine. 

    The same issue of BetterInvesting Magazine will also include a fundamental review of ICON PLC (NASDAQ:ICLR) which the independent Editorial Advisory and Securities Review Committee believes is worthy of further study from an undervalued perspective. 

    Committee members are Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Walter J. Kirchberger, CFA; Anne Nichols, CFA; and Dan Rutter, CFA.

    Securities mentioned are for study and presented for educational purposes only. They are not to be considered as endorsed or recommended for purchase by NAIC/BetterInvesting. Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision.

    About BetterInvesting:

    BetterInvesting™, a national 501(c)(3) nonprofit, investment education organization, has been empowering everyday Americans since 1951. Also known as the National Association of Investors™ (NAIC®), we have helped more than 5 million people from all walks of life learn how to improve their financial future. BetterInvesting provides unbiased, in-depth investing education and powerful online stock analysis tools to create successful lifelong investors. BetterInvesting staff, along with a dedicated community of volunteers across America, teach the organization's principles and time-tested methodology to individuals and investment clubs. For more information about BetterInvesting, please visit www.betterinvesting.org

    Follow us on LinkedIn, Instagram and Facebook.

    Contact: 877-275-6242

    Cision View original content:https://www.prnewswire.com/news-releases/betterinvesting-magazine-update-on-lowes-cos-nyse-low-and-icon-plc-nasdaq-iclr-302409748.html

    SOURCE National Association of Investors Corporation/BetterInvesting

    Get the next $ICLR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ICLR
    $LOW

    CompanyDatePrice TargetRatingAnalyst
    Lowe's Companies Inc.
    $LOW
    11/20/2025$305.00 → $285.00Outperform
    Telsey Advisory Group
    ICON plc
    $ICLR
    11/13/2025$175.00Market Perform
    BMO Capital Markets
    ICON plc
    $ICLR
    9/9/2025$175.00Buy → Hold
    Jefferies
    ICON plc
    $ICLR
    9/3/2025$236.00Neutral → Buy
    Rothschild & Co Redburn
    ICON plc
    $ICLR
    8/21/2025$200.00Buy → Neutral
    Citigroup
    ICON plc
    $ICLR
    7/24/2025$224.00Neutral → Outperform
    Robert W. Baird
    ICON plc
    $ICLR
    4/29/2025$150.00Overweight → Neutral
    Analyst
    Lowe's Companies Inc.
    $LOW
    4/25/2025$266.00Sector Weight → Overweight
    KeyBanc Capital Markets
    More analyst ratings

    $ICLR
    $LOW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Tax & CAO Griggs Dan Clayton Jr gifted 149 shares, decreasing direct ownership by 1% to 11,681 units (SEC Form 4)

    4 - LOWES COMPANIES INC (0000060667) (Issuer)

    12/10/25 4:17:16 PM ET
    $LOW
    RETAIL: Building Materials
    Consumer Discretionary

    Director Simkins Lawrence bought $231,063 worth of shares (1,000 units at $231.06), increasing direct ownership by 100% to 2,000 units (SEC Form 4)

    4 - LOWES COMPANIES INC (0000060667) (Issuer)

    11/25/25 4:21:18 PM ET
    $LOW
    RETAIL: Building Materials
    Consumer Discretionary

    SEC Form 4 filed by Director Alvarez Ralph

    4 - LOWES COMPANIES INC (0000060667) (Issuer)

    10/2/25 4:13:53 PM ET
    $LOW
    RETAIL: Building Materials
    Consumer Discretionary

    $ICLR
    $LOW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive

    ICON plc (NASDAQ:ICLR), a world-leading clinical research organisation, today released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update of our 2023 survey, while the second survey focused exclusively on trends in the rapidly growing Chinese biotech market. In total, both surveys captured insights from more than 260 biotech professionals and venture capital executives across the US, Europe, Asia-Pacific (APAC) and the Middle East. ICON's global biotech sector survey of 163 biotech respondents highlights the resilience of the industry, driven by investment in APAC markets and shifts in R&D priorities since its last survey in 2023. I

    12/9/25 7:15:00 AM ET
    $ICLR
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

    ICON plc (NASDAQ:ICLR), a world-leading clinical research organisation, today announced results of its latest industry survey, examining the challenges clinical trial sites face during study startup. The findings underscore the need for a site-centric, collaborative approach to overcome bottlenecks and enhance trial activation timelines. The survey, conducted in June 2025 among just over 100 principal investigators and senior clinical trial site personnel, gathered perspectives from a wide range of clinical trial sites and is not limited to studies managed by ICON. It reveals widespread sentiment that sites are increasingly burdened by operational bottlenecks, contract and budget delays, a

    12/2/25 7:15:00 AM ET
    $ICLR
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    LOWE'S TO PARTICIPATE IN MORGAN STANLEY GLOBAL CONSUMER & RETAIL CONFERENCE

    MOORESVILLE, N.C., Nov. 25, 2025 /PRNewswire/ -- Lowe's Companies, Inc. (NYSE:LOW) announces that Marvin R. Ellison, chairman and chief executive officer, will participate in a fireside chat at the Morgan Stanley Global Consumer & Retail Conference. What: Marvin Ellison participating in a fireside chat at the Morgan Stanley Global Consumer & Retail Conference When: 8:45 a.m. ET on Tuesday, Dec. 2, 2025 Where: Listen to the audio webcast at ir.lowes.com under "Events & Presentations"The archived webcast will be available at the same location approximately 24 hours after the ev

    11/25/25 4:30:00 PM ET
    $LOW
    RETAIL: Building Materials
    Consumer Discretionary

    $ICLR
    $LOW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Simkins Lawrence bought $231,063 worth of shares (1,000 units at $231.06), increasing direct ownership by 100% to 2,000 units (SEC Form 4)

    4 - LOWES COMPANIES INC (0000060667) (Issuer)

    11/25/25 4:21:18 PM ET
    $LOW
    RETAIL: Building Materials
    Consumer Discretionary

    Director Simkins Lawrence bought $245,532 worth of shares (1,000 units at $245.53) (SEC Form 4)

    4 - LOWES COMPANIES INC (0000060667) (Issuer)

    12/23/24 4:10:11 PM ET
    $LOW
    RETAIL: Building Materials
    Consumer Discretionary

    $ICLR
    $LOW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Telsey Advisory Group reiterated coverage on Lowe's with a new price target

    Telsey Advisory Group reiterated coverage of Lowe's with a rating of Outperform and set a new price target of $285.00 from $305.00 previously

    11/20/25 7:53:46 AM ET
    $LOW
    RETAIL: Building Materials
    Consumer Discretionary

    BMO Capital Markets initiated coverage on ICON plc with a new price target

    BMO Capital Markets initiated coverage of ICON plc with a rating of Market Perform and set a new price target of $175.00

    11/13/25 9:13:59 AM ET
    $ICLR
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    ICON plc downgraded by Jefferies with a new price target

    Jefferies downgraded ICON plc from Buy to Hold and set a new price target of $175.00

    9/9/25 7:54:46 AM ET
    $ICLR
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $ICLR
    $LOW
    SEC Filings

    View All

    SEC Form 10-Q filed by Lowe's Companies Inc.

    10-Q - LOWES COMPANIES INC (0000060667) (Filer)

    11/26/25 4:34:01 PM ET
    $LOW
    RETAIL: Building Materials
    Consumer Discretionary

    Lowe's Companies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - LOWES COMPANIES INC (0000060667) (Filer)

    11/19/25 8:45:10 AM ET
    $LOW
    RETAIL: Building Materials
    Consumer Discretionary

    SEC Form SCHEDULE 13G filed by ICON plc

    SCHEDULE 13G - ICON PLC (0001060955) (Subject)

    11/14/25 12:59:35 PM ET
    $ICLR
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    $ICLR
    $LOW
    Leadership Updates

    Live Leadership Updates

    View All

    ICON Announces CEO Transition

    ICON plc (NASDAQ:ICLR), a world-leading clinical research organisation, today announced that Dr. Steve Cutler has informed the Board of his decision to retire as Chief Executive Officer and the Board has appointed Mr. Barry Balfe, ICON's Chief Operating Officer, to succeed Dr. Cutler as Chief Executive Officer effective 1 October 2025. Mr. Balfe has also been appointed to the Board. Dr. Cutler will continue to serve on the Board as a non-executive director to facilitate a smooth transition. Mr. Balfe has deep knowledge of the CRO industry and has served as ICON's Chief Operating Officer since January 2025. Prior to his appointment as Chief Operating Officer, Mr. Balfe was appointed to the

    9/4/25 8:00:00 AM ET
    $ICLR
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    ICON Announces Results of Annual General Meeting

    ICON plc (NASDAQ:ICLR), a world-leading clinical research organisation powered by healthcare intelligence, today announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 22, 2025 were duly passed by shareholders. These resolutions were set out in the Notice of the AGM sent to shareholders dated June 11, 2025 and are available on the ICON plc website. Forms of Proxy were received by ICON plc before the meeting, appointing proxies and giving them the following voting instructions: RESOLUTION NUMBER RESOLUTION     TOTAL NUMBER OF VOTES     VOTE FOR     VOTE AGAINST     VOTE WITHHELD                   1.1

    7/23/25 4:20:00 PM ET
    $ICLR
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    Shareholders Elect Four Independent Directors to the Six Flags Board

    Six Flags Entertainment Corporation (NYSE:FUN), the largest regional amusement park operator in North America, announced today that its shareholders elected Sandra (Sandy) Cochran, Michael Colglazier, Felipe Dutra, and Steven Hoffman to the Board of Directors of Six Flags Entertainment Corporation for 3-year terms expiring in 2028. Shareholders also confirmed the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm, approved an advisory vote on the compensation of the Company's named executive officers, and confirmed a 1-year frequency for shareholder advisory votes on executive compensation. "I want to welcome Sandy, Michael, Felipe and St

    6/25/25 5:00:00 PM ET
    $BUD
    $CBRL
    $DG
    Beverages (Production/Distribution)
    Consumer Staples
    Restaurants
    Consumer Discretionary

    $ICLR
    $LOW
    Financials

    Live finance-specific insights

    View All

    LOWE'S REPORTS THIRD QUARTER 2025 SALES AND EARNINGS RESULTS

    — Diluted EPS of $2.88; Adjusted Diluted EPS1 of $3.06 —— Comparable Sales increased 0.4% —— Updates Full Year 2025 Outlook — MOORESVILLE, N.C., Nov. 19, 2025 /PRNewswire/ -- Lowe's Companies, Inc. (NYSE:LOW) today reported net earnings of $1.6 billion and diluted earnings per share (EPS) of $2.88 for the quarter ended Oct. 31, 2025, compared to diluted EPS of $2.99 in the third quarter of 2024. During the third quarter, the company recognized $129 million in pre-tax expenses associated with the acquisitions of Foundation Building Materials (FBM) and Artisan Design Group (ADG). Excluding these expenses, third quarter 2025 adjusted diluted EPS1 increased 5.9% to $3.06 compared to the prior-ye

    11/19/25 6:00:00 AM ET
    $LOW
    RETAIL: Building Materials
    Consumer Discretionary

    LOWE'S COMPANIES, INC. DECLARES CASH DIVIDEND

    MOORESVILLE, N.C., Nov. 14, 2025 /PRNewswire/ -- The board of directors of Lowe's Companies, Inc. (NYSE:LOW) has declared a quarterly cash dividend of one dollar and 20 cents ($1.20) per share, payable Feb. 4, 2026, to shareholders of record as of Jan. 21, 2026.  About Lowe's Lowe's Companies, Inc. (NYSE:LOW) is a FORTUNE® 100 home improvement company serving approximately 16 million customer transactions a week, with total fiscal 2024 sales of more than $83 billion. Lowe's employs approximately 300,000 associates and operates over 1,700 home improvement stores, 530 branches a

    11/14/25 4:30:00 PM ET
    $LOW
    RETAIL: Building Materials
    Consumer Discretionary

    Lowe's Companies, Inc. to Host Third Quarter 2025 Earnings Conference Call on Nov. 19

    MOORESVILLE, N.C., Nov. 12, 2025 /PRNewswire/ -- Lowe's Companies, Inc. (NYSE:LOW) announced today that it will hold its Third Quarter 2025 Earnings Conference Call at 9 a.m. Eastern time on Wednesday, Nov. 19. A webcast will be available by visiting the Quarterly Earnings section of the Lowe's Investor Relations website, ir.lowes.com. Supplemental materials will be available 15 minutes before the start of the conference call. What: Third Quarter 2025 Earnings Conference Call When: 9 a.m. ET on Wednesday, Nov. 19 Where: Visit the Quarterly Earnings section of the Lowe's Invest

    11/12/25 6:00:00 AM ET
    $LOW
    RETAIL: Building Materials
    Consumer Discretionary

    $ICLR
    $LOW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by ICON plc

    SC 13G/A - ICON PLC (0001060955) (Subject)

    11/12/24 11:54:03 AM ET
    $ICLR
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    SEC Form SC 13G/A filed by ICON plc (Amendment)

    SC 13G/A - ICON PLC (0001060955) (Subject)

    2/9/24 11:49:03 AM ET
    $ICLR
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care

    SEC Form SC 13G/A filed by ICON plc (Amendment)

    SC 13G/A - ICON PLC (0001060955) (Subject)

    1/30/24 12:11:57 PM ET
    $ICLR
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care